Traws Pharma, Inc.

TRAW·NASDAQ·$1.58Share Price as of 11/2·$14MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-K/AFY 202504/30/26 10-KFY 202504/15/26 10-QQ3 ended 09/30/2511/13/25

Disclosures

8-KCurrent report10/23/26 8-KCurrent report08/14/26 8-KCurrent report07/31/26 8-KCurrent report07/10/26 8-KCurrent report07/09/26

Prospectuses and Registrations

S-1Registration statement (IPO)10/26/26 424B5Prospectus supplement07/10/26 S-3Shelf registration07/01/26 424B5Prospectus supplement05/22/26 424B3Prospectus05/15/26

Proxies

DEF 14ADefinitive proxy10/20/26 DEFA14AAdditional proxy materials10/20/26 PRE 14APreliminary proxy10/08/26 DEF 14ADefinitive proxy05/29/26 DEFA14AAdditional proxy materials05/29/26

Ownership

SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/12/26 Form 4Insider transaction07/16/26

Other

EFFECTRequest for effectiveness07/09/26 CORRESPCorrespondence with the SEC07/07/26 UPLOADLetter from the SEC07/07/26 ARSAnnual report to shareholders05/29/26 EFFECTRequest for effectiveness05/15/26